A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

Trial Details

NCT ID

NCT06609005

Phase

PHASE1 / PHASE2

Sponsor

Shenzhen Ionova Life Sciences Co., Ltd.

Status

RECRUITING

Cancer Type

Prostate Cancer

Interventions

• INV-9956

Locations (sample)

• Scottsdale, Arizona, United States|33.50921,-111.89903
• Newport Beach, California, United States|33.61891,-117.92895
• Orange, California, United States|33.78779,-117.85311
• Houston, Texas, United States|29.76328,-95.36327
• San Antonio, Texas, United States|29.42412,-98.49363

Key Eligibility Criteria

• Written informed consent obtained.
• Male aged ≥ 18 years.
• Histologically confirmed adenocarcinoma of the prostate.
• Castration resistant prostate cancer with serum testosterone \<50 ng/dL.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.